Immune modulation
Changes in immune activity or inflammatory response.
Peptides linked to this mechanism
LL-37 is an investigational peptide, analogue or research construct with evidence ranging from mechanistic studies to limited human trials.
A synthetic dipeptide promoted for immune, thymic and healthy-ageing effects, supported mainly by preclinical and regional literature.
Thymosin Alpha 1 is an investigational peptide, analogue or research construct with evidence ranging from mechanistic studies to limited human trials.
Thymulin is an endogenous signalling peptide with established or emerging physiological relevance.
A 28-amino-acid endogenous neuropeptide that activates VPAC receptors and regulates vascular, pulmonary, gastrointestinal, neural and immune functions.
Thymopentin is an investigational peptide, analogue or research construct with evidence ranging from mechanistic studies to limited human trials.
Thymogen is an organ-associated short peptide promoted for regulatory effects, but independent modern clinical evidence is sparse.